|
Press Releases |
|
|
|
Wednesday, September 8, 2021 |
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药,一家专注于肿瘤治疗领域的创新型全球生物制药公司,今日宣布其口服泛PI3K抑制剂buparlisib(AN2025)、口服EP4拮抗剂(AN0025)与PD-L1抑制剂atezolizumab(阿替利珠单抗)三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。 more info >> |
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
阿諾醫藥,一家專注於腫瘤治療領域的創新型全球生物製藥公司,今日宣佈其口服泛PI3K抑制劑buparlisib(AN2025)、口服EP4拮抗劑(AN0025)與PD-L1抑制劑atezolizumab(阿替利珠單抗)三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
Thursday, July 15, 2021 |
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
ランドクルーザー、新型車"250"シリーズを発売
Apr 18, 2024 15:00: JST
|
|
|
Honda、「N-VAN」を一部改良し発売
Apr 18, 2024 15:00: JST
|
|
|
三菱重工と日本ガイシ、アンモニア分解ガスからの膜分離水素精製システムを共同開発
Apr 18, 2024 14:00: JST
|
|
|
Microex Launches Web3.0 Financial Trading Solution - Pioneering Innovation in Financial Technology
Apr 18, 2024 14:00 HKT/SGT
|
|
|
PAREMINAが革新的な抗老化ソリューションを携えて、Beautyworld Tokyo 2024でアジア初上陸を発表
Apr 18, 2024 13:45: JST
|
|
|
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
|
|
|
To acquire stake in Hangzhou Bizike, Phoenitron Holdings has eye on trillion-dollar e-commerce market
Apr 18, 2024 11:51 HKT/SGT
|
|
|
The Executive Centre Announces Record Revenue in FY2023 Annual Results
Apr 18, 2024 11:00: JST
|
|
|
富士通とオラクル、日本市場におけるデータ主権要件に対応するソブリンクラウドの提供に向け戦略的協業
Apr 18, 2024 11:00: JST
|
|
|
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
|
|
|
德事宣布2023年收入创新高
Apr 18, 2024 10:02 HKT/SGT
|
|
|
德事商務中心(TEC)2023年收入創新高
Apr 18, 2024 10:01 HKT/SGT
|
|
|
The Executive Centre Announces Record Revenue in FY2023 Annual Results
Apr 18, 2024 10:00 HKT/SGT
|
|
|
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
|
|
|
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 9:22 JST
|
|
|
|
More News >> |
|
|
|
|
|